Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells

BioFactors

Volumn 29, Issue 4, 2007, Pages 187-202

  Kim, Seok Kwun ^a   Kwon, Ji Young ^b   Nam, Taek Jeong ^b  

^a Dong A University   (South Korea)

^b Pukyong National University   (South Korea)

Author keywords

Extracellular matrix; Extracellular signal regulated kinases 1 and 2; IGF binding protein 5; Insulin like growth factor (IGF) I; MC3T3 E1 osteoblast cells

Indexed keywords

DISINTEGRIN; ECHISTATIN; GROWTH FACTOR; INSULIN RECEPTOR SUBSTRATE 1; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OSTEOPONTIN; SCLEROPROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THROMBOSPONDIN 1; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

3T3 CELLS; ANIMALS; BINDING SITES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHAVBETA3; LIGANDS; MICE; OSTEOBLASTS; OSTEOPONTIN; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1;

EID: 36549048884     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520290403     Document Type: Article

References (51)

1. C.K. Abrass, A.K. Berfield and D.L. Andress, Heparin binding domain of IGFBP-5 stimulates mesengial cell migration, Am J Physiol 273 (1997), F899-F906.
2. D.L. Andress, Heparin modulates the binding of insulin-like growth factor (IGF-I) binding protein-5 to a membrane protein in osteoblastic cells, J Biol Chem 270 (1995), 289-296.
3. D.L. Andress and R.S. Birnbaum, Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF actions, J Biol Chem 267 (1992), 22467-22472.
4. T. Arai, A.J. Parker, W.H. Busby and D.R. Clemmons, Heparin, heparin sulfate and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor binding protein complexes, J Biol Chem 269 (1994), 20399-20393.
5. R. Baserga, The IGF-I receptor in cancer research, Exp Cell Res 253 (1999), 1-6.
6. A.K. Berfield, D.L. Andress and C.K. Abrass, IGFBP-5 (201-218) stimulates Cdc42GAP aggregation and filopodia formation migrating mesengial cells, Kidney Int 57 (2000), 1991-2003.
7. A.L. Boskey, Biomineralization: Conflicts, challenges, and opportunities, J Cell Biochem (Suppl) (1998), 30-31.
8. T.V. Byzova and E.F. Plow, Activation of αVβ3 on vascular cells controls recognition of prothrombin, J Cell Biol 28 (1998), 2081-2092.
9. E. Canalis, Insulin-like growth factors and the local regulation of bone formation, Bone 14 (1993), 273-276.
10. L.A. Cary and J.L. Guan, Focal adhesion kinase in integrin-mediated signaling, Front Biosci 4 (1999), D102-D113.
11. E.A. Clark and J.S. Brugge, Integrins and signal transduction pathways: the road taken, Science 268 (1995), 233-239.
12. C.A. Conover and M.C. Kiefer, Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells, J Clin Endocrinol Metab 76 (1993), 1153-1159.
13. Y. Dong and E. Canalis, Insulin-like growth factor I and retinoic acid induce the synthesis of insulin-like growth factor binding protein-5 in rat osteoblastic cells, Endocrinology 136 (1995), 2000-2006.
14. B.P. Eliceiri, R. Klemke, S. Stromblad and D.A. Cheresh, Integrin αVβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis, J Cell Biol 140 (1998), 1255-1263.
15. B. Gabbitas and E. Canalis, Insulin-like growth factors sustain insulin-like growth factor binding protein-5 expression in osteoblasts, Am J Physiol 275 (1998), E222-E228.
16. C.M. Giachelli, N. Bae, M. Almeida, D.T. Denhard, C.E. Alpers and S.M. Schwarts, Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques, J Clin Invest 92 (1993), 1686-1696.
17. F.G. Giancotti, Complexity and specificity of integrin signaling, Nat Cell Bio 2 (2002), E13-E14.
18. M.J. Glimcher, Mechanism of calcification: Role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo, Anat Rec 224 (1989), 139-153.
19. R.O. Hynes, Integrins: Versatility, modulation and signaling in cell adhesion, Cell 69 (1992), 11-25.
20. J.I. Jones, A. Gockerman, W.H. Busby, C. Camacho-Hubner and D.R. Clemmons, Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I, J Cell Biol 121 (1993), 679-687.
21. J.I. Jones, A. Gockerman, W.H. Busby, G. Wright and D.R. Clemmons, IGFBP-1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence, Proc Natl Acad Sci USA 90 (1993), 10553-10557.
22. J.I. Jones, P.A. Gockerman and D.R. Clemmons, Ligand occupancy of αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor, Proc Natl Acad Sci USA 93 (1996), 2482-2487.
23. J.I. Jones, T. Prevette, A. Gockerman and D.R. Clemmons, Ligand occupancy of the v3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I, Proc Natl Acad Sci USA 93 (1996), 2482-2487.
24. T. Kaji, T. Fujiwara, C. Yamamoto, M. Sakamoto and H. Kozuka, Stimulation of cultured vascular smooth muscle cell proliferation by thrombospondin is potentiated by zinc, Biol Pharm Bull 18 (1995), 1264-1266.
25. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg and K.F. Friend, The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr Rev 21 (2000), 215-244.
26. D. LeRoith, H. Werner, D. Beitner-Johnson and D.C. Roberts, Molecular and cellular aspects of the insulin-like growth factor I receptor, Endocr Rev 16 (1995), 143-163.
27. B.A. Lessey, Adhesion molecules and implantation, J Reprod Immunol 55 (2002), 101-112.
28. L. Liaw, M.D. Skinner, E.W. Raines, R. Ross, D.A. Cheresh, S.M. Schwartz and C.M. Giachelli, The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of αvβ3 in smooth muscle cell migration to osteopontin in vitro, J Clin Invest 95 (1995), 713-724.
29. T.A. Linkhart, S. Mohan and D.J. Baylink, Growth factors for bone growth and repair: IGF, TGFβ and BMP, Bone 19 (1996), 1S-12S.
30. C. McCaig, C.M. Perks and J.M. Holly, Signaling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival, J Cell Biochem 84 (2002), 784-794.
31. C. McCaig, C.M. Perks and J.M.P. Holly, IGF-independent effects of IGFBP-5 on breast epithelial cell survival and attachment are blocked by a synthetic RGD-containing peptide. Proceedings of the Endocrine Society's 83rd Annual Meeting, Denver (2001), P2-P263.
32. N. Miyakoshi, C. Richman, Y. Kasukawa, T.A. Linkhart, D.J. Baylink and S. Mohan, Evidence that IGFBP-5 functions as a growth factor, J Clin Invest 107 (2001), 73-81.
33. T.J. Nam, W.H. Busby and D.R. Clemmons, Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I, Endocrinology 138 (1997), 2972-2998.
34. Y. Oh, H.L. Muller, H. Pham and R.D. Rosenfeld, Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells, J Biol Chem 268 (1993), 26045-26048.
35. J.E. Onyia, B. Miller, J. Hulman, J. Liang, R. Galvin, C. Frolik, S. Chandrasekhar, A.K. Harvey, J. Bidwell, J. Herring and J.M. Hock, Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro, Bone 20 (1997), 93-100.
36. N. Pampori, T. Hato, D. G. Stupack, S. Aidoudi, D.A. Cheresh, G.R. Nemerow and S.J. Shattil, Mechanism and consequences of affinity modulation of integrin αVβ3 detected with a novel patch-engineered monovalent ligand, J Biol Chem 274 (1999), 21609-21616.
37. A. Parker, W.H. Busby and D.R. Clemmons, Identification of the extracellular matrix binding site for insulin like growth factor binding protein-5, J Biol Chem 271 (1996), 13523-13529.
38. A.J. Pelletier, T. Kunicki, Z.M. Ruggery and V. Quaranta, The activation state of the integrin αII6β3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation, J Biol Chem 270 (1995), 18133-18140.
39. A. Pelletier, T. Kunichi and V. Quaranta, Activation of the integrin αVβ3 involves a discrete cation-binding site that regulates conformation, J Biol Chem 271 (1996), 1364-1370.
40. C.M. Perks and J.M.P. Holly, Insulin-like growth factor binding protein 3 (IGFBP-3) modulates the phosphorylation of focal adhesion kinase (FAK) independently of IGF in Hs578T human breast cancer cells, Growth Horm IGF Res 9 (1999), P112.
41. S.B. Rodan and G.A. Rodan, Integrin function in osteoclasts, J Endocrinol 154 (1997), S47-S56.
42. K.I. Rother and D. Accili, Role of insulin receptors and IGF receptors in growth and development, Pediatr Nephrol 14 (2000), 558-561.
43. S.J. Shatril and M.H. Ginsberg, Integrin signaling in vascular biology, J Clin Invest 100 (1997), 1-5.
44. G. Stouffer, Z. Hu, M. Sajid, H. Li, G. Jin, M.T. Nakada, S.R. Hanson and M.S. Runge, Beta 3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells, Circulation 97 (1998), 907-915.
45. Y. Takeuchi, K. Nakayama and T. Matsumoto, Differentiation and cell surface expression of transforming growth factor-receptors are regulated by interaction with matrix collagen in murine osteoblastic cells, J Biol Chem 271 (1996), 3938-3944.
46. K.M. Thrailkill, S.R. Siddhanti, J.L. Fowlkes and L.D. Quarles, Differentiation of MC3T3-E1 cells is associated with temporal changes in the expression of IGF-I and IGFBPs, Bone 17 (1995), 307-313.
47. J. Wei, L.M. Shaw and A.M. Mercurio, Regulation of mitogen-activated protein kinase activation by the cytoplasmic domain of the α6 integrin subunit, J Biol Chem 273 (1998), 5903-5907.
48. L.A. Wetterau, M.G. Moore, K.W. Lee, M.L. Shim and P. Cohen, Novel aspects of the insulin-like growth factor binding proteins, Mol Genet and Metab 68 (1999), 161-181.
49. J.W. Xuan, C. Hotu, Y. Shigeyama, J.A. D'Errico, M.J. Somerman and A.F. Chambers, Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migratory functions, J Cell Biochem 57 (1995), 680-690.
50. X. Yu, S.C. Heieh, W. Bao and D.T. Graves, Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures, Am J Physiol 272 (1997), C1709-C1716.
51. B. Zheng and D.R. Clemmons, Blocking ligand occupancy of the v3 integrin inhibits IGF-I signaling in vascular smooth muscle cells, Proc Natl Acad Sci USA 95 (1998), 11217-11222.